Taken together, our data, along with previous findings showing the activation of RAC1 downstream of EGFR via DOCK418 suggest that BEC-secreted factors, including EGF, activate EGFR and RAC1 via DOCK4 to promote an elongated phenotype and extravasation competency of tripe-negative breast cancer cells. Here, DOCK4 is linked to breast carcinoma.